In a groundbreaking move, the U.S. Department of Veterans Affairs (VA) is launching new studies on using psychedelic compounds to treat post-traumatic stress disorder (PTSD) and depression among military veterans. This marks a significant shift for the VA, representing the first such research since the 1960s, reported Military Times. This new VA-backed effort will delve deeper into “the effectiveness and safety of using MDMA and psilocybin-augmented psychotherapy in veterans,” as the VA release outlined. The decision comes on the heels of mounting evidence suggesting the positive impact of MDM…
